Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Statements Author contributions XZ and MW mainly wrote and revised the manuscripts, and constructed the framework of the manuscript
Lifestyle modifications resulting in weight loss led to an increase in HDL-C and decrease in LDL-C, triglycerides, and apoB
NAFLD is a basic umbrella term to describe the entire spectrum of non-alcoholic fatty liver disease
But one active clinical trial, registered as NCT07092605 on ClinicalTrials.gov, is now specifically studying the effectiveness of microdosed GLP-1 receptor agonists for improving health and quality of life in patients who do not meet traditional prescribing criteria
Alternatives to GLP-1 patches If youre trying to lose weight safely and effectively, there are far more effective approaches than using a patch